Thai Court Reinstates Pro-Compulsory Licensing Board
This article was originally published in PharmAsia News
Thailand's Administrative Court ordered reinstated six members of the Government Pharmaceutical Organisation who advocated the country's controversial compulsory-licensing policy. Among the six was the former GPO chairman, Vichai Chokewiwat, who had been sacked by the Public Health Minister Chaiya Sasomsab. Chaiya, a strong opponent of the compulsory-licensing policy for major drugs, fired the six on grounds of declining profits. Vichai said he would arrange an early meeting of the old board, with its first move to speed up the import of generic versions of Sanofi-Aventis' oncologic Taxotere (docetaxel), one of the drugs on Thailand's compulsory licensing list. (Click here for more
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.